Penumbra (PEN) Free Cash Flow (QoQ) (2015 - 2026)
Penumbra (PEN) Free Cash Flow (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.12% |
| Dec 31, 2025 | -3.52% |
| Sep 30, 2025 | 386.54% |
| Jun 30, 2025 | -62.69% |
| Mar 31, 2025 | 3.29% |
| Dec 31, 2024 | -10.35% |
| Sep 30, 2024 | 182.25% |
| Jun 30, 2024 | -44.33% |
| Mar 31, 2024 | -10.68% |
| Dec 31, 2023 | 17.13% |
| Sep 30, 2023 | 78.25% |
| Jun 30, 2023 | 53.44% |
| Mar 31, 2023 | -23.22% |
| Dec 31, 2022 | 176.75% |
| Sep 30, 2022 | 56.24% |
| Jun 30, 2022 | -364.64% |
| Mar 31, 2022 | 63.02% |
| Dec 31, 2021 | -175.67% |
| Sep 30, 2021 | 2,276.66% |
| Jun 30, 2021 | 91.53% |